J. Wust et U. Hardegger, IN-VITRO ACTIVITY OF CEFTRIAXONE COMBINED WITH TAZOBACTAM AGAINST ANAEROBIC-BACTERIA, European journal of clinical microbiology & infectious diseases, 13(2), 1994, pp. 177-181
The in vitro activity of ceftriaxone combined with tazobactam against
190 strains of anaerobic bacteria was compared with that of amoxicilli
n with clavulanic acid, ampicillin with sulbactam, piperacillin alone
and with tazobactam, cefoxitin, and imipenem, i.e. beta-lactam antibio
tics established in the treatment of anaerobic infections. All anaerob
es tested were susceptible to less-than-or-equal-to 32 mg/l ceftriaxon
e when tazobactam was added at fixed ratios (ceftriaxone to tazobactam
) of 2:1 and 8:1 and at constant concentrations of 2,4 and 8 mg/l, res
pectively. When 4 mg/l tazobactam was added, the MICs of ceftriaxone f
or 83 of 94 strains of the Bacteroides fragilis group were reduced by
a factor of 8 to 512; for eight strains, this reduction was two to fou
rfold. Only the MICs of ceftriaxone for three Bacteroides fragilis str
ains were not influenced.